Pfizer starts trials of potential blockbuster (Long Island Business News) Pfizer and a North Carolina-based biotech company have begun clinical trials of a potential blockbuster drug developed by Stony Brook University researchers. Although there's no guarantee the drug will advance through clinical trials successfully, Stony Brook said the painkiller "with no apparent side effects or addictive qualities" could be "only a year or two from the consumer market."
House's Science Cuts Threaten Our Future (Huffington Post Op-Ed) When Newt Gingrich asked physicist-congressman Vern Ehlers to update "Science, the Endless Frontier" - the pathbreaking vision for post-World War II science - Ehlers called his own 1998 report "Unlocking our Future." Ehlers perceived that the enormous potential benefits of science demanded a stable and thoughtful federal science investment to unlock them. He could hardly have imagined that Congress might someday propose the reverse - to lock up the future by suspending critical parts of the nation's technical machinery that we need to survive in an increasingly complex and volatile world.